期刊文献+

高危型人乳头瘤病毒感染与宫颈鳞状上皮内病变的相关性分析 被引量:14

Correlation analysis between high-risk human papillomavirus infection and cervical squamous intraepithelial lesions
原文传递
导出
摘要 目的分析高危型人乳头瘤病毒(high-risk human papillomavirus,HR-HPV)感染在不同级别宫颈鳞状上皮内病变中的亚型分布特点,探讨HR-HPV分型检测对宫颈病变诊治的指导价值.方法采用回顾性病例对照分析方法,收集2020年1~12月于北京天坛医院行阴道镜检查+宫颈活检,病理证实CIN 2和CIN 3共183例,CIN 1共137例,同时收集病理结果为正常/炎症改变285例,所有患者均有HR-HPV感染.结果CIN 2/3组中,HR-HPV检出率最高的前5位分别为HPV16(47.54%)、HPV52(21.31%)、HPV58(12.57%)、HPV31(8.74%)、HPV 18(8.20%),以HR-HPV单一感染多见,其中HPV16亚型感染最常见(42.27%).单因素分析表明,不同年龄段、不同怀孕次数和不同HPV16感染状态下,宫颈病变程度差异有统计学意义(P<0.05);HR-HPV多重感染与宫颈病变程度进展有显著的相关关系(P<0.001).多因素Logistic回归结果表明,"HPV16阳性"以及"HPV31阳性"为宫颈病变程度的独立危险因素.结论HR-HPV感染在CIN 2/3组中,以HPV16/52/58/31/18感染多见;相对其他HR-HPV亚型,HPV16、HPV31以及多个亚型的混合感染与宫颈病变程度具有较大相关性,临床上应当给予高度重视,加强管理和随访. Objective To analyze the subtype distribution characteristics of high-risk human papillomavirus(HR-HPV)infection in different grades of cervical squamous intraepithelial lesions,and to explore the guiding value of HR-HPV typing in the diagnosis and treatment of cervical lesions.Methods A retrospective case-control analysis method was used to collect patients underwent colposcopy+cervical biopsy in Beijing Tiantan Hospital from January to December 2020.Including 183 cervical intraepithelial neoplasia(CIN)2/3 cases,137 CIN 1 cases and 285 normal cervix/chronic cervicitis cases.All cases were pathologically confirmed and all patients had HR-HPV infection.Results In the CIN 2/3 group,the top 5 HR-HPV detection rates were HPV16(47.54%),HPV52(21.31%),HPV58(12.57%),HPV31(8.74%),and HPV18(8.20%),respectively.HR-HPV single infection was more common,and HPV16 subtype infection was the most common(42.27%).Univariate analysis showed that there were significant differences in the degree of cervical lesions among different age groups,different times of pregnancy and different HPV16 infection status;Multiple HR-HPV infection was significantly correlated with the progression of cervical lesions(P<0.001).Multivariate Logistic regression and variable screening results showed that"HPV16 positive"and"HPV31 positive"were independent risk factors for the degree of cervical lesions.Conclusion In the CIN 2/3 group,HR-HPV infection was more common with HPV16/52/58/31/18 infection;compared with other HR-HPV subtypes,HPV16,HPV31 and mixed infection of multiple subtypes were associated with the progression of cervical lesions.It should be highly valued in clinical practice,and management and follow-up should be strengthened.
作者 李海霞 李春霞 杨保军 赵辉 冯力民 Li Haixia;Li Chunxia;Yang Baojun;Zhao Hui;Feng Limin(Department of Obsterics and Gynecology,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,P.R.China)
出处 《中国计划生育和妇产科》 2022年第6期60-64,共5页 Chinese Journal of Family Planning & Gynecotokology
关键词 人乳头瘤病毒 高危型 宫颈病变 human papillomavirus high-risk cervical lesions
  • 相关文献

参考文献4

二级参考文献45

  • 1杨英捷,赵健,李雪倩,廖秦平.人乳头状瘤病毒不同亚型感染与宫颈病变的相关性[J].中国妇产科临床杂志,2006,7(4):253-256. 被引量:54
  • 2Schlecht NF,Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia[ J ]. JAMA ,2001,286 ( 24 ) : 3106-3114. 被引量:1
  • 3Schiffman M, Castle PE, Jeronimo J, et al. Human papilloma- virus and cervical cancer[ J]. Lancet,2007,370:890-907. 被引量:1
  • 4Thomas C, Wright JR, Steward LM, et al. 2006 Concensus guide- lines for the management of women with abnormal cervical cancer screening tests[ J 1. Oncolgy, 2007, 10 : 346-355. 被引量:1
  • 5Stewart LM, Mark HE, Warner KH, et al. 2012 updated consen- sus guidelines for the management of abnormal cervical cancer screening test and cancer precursors [ J ]. J Lower Genit Tract Dis ,2013,17 : sl -s27. 被引量:1
  • 6Clavel C, Masure M, Bory JP, et al. Human papillomavirus tes- ting in primary screening for the detection of high-grade cervical lesions: A study of 7932 women[J]. Br J Cancer, 2001, 84 : 1616-1623. 被引量:1
  • 7Katki HA, Kinney WK, Fettennan B, et al. Cervical cancer risk for 330,000 women undergoing concurrent HPV testing and cer- vical cytology in routine clinical practice at a large managed care organization [ J ]. Lancet Onco1,2011,12 ( 7 ) :663 4572. 被引量:1
  • 8Katki HA, Schiffman M, Castle PE,et al. Five-Year risks of CIN 3 + and cervical cancer among women who test Pap-negative but are HPV-positive [ J ]. J Low Genit Tract Dis,2013,17 :$56- $63. 被引量:1
  • 9Wheeler CM, Hunt WC, Joste NE, et al. Human Papillomavirus Genotype Distributions: Implications for Vaccination and CancerScreening in the United States [ J 1- J Natl Cancer Inst, 2009, 101 : 475-487. 被引量:1
  • 10Clifford GM, Smith JS, Plummer M, et al. Human papilloma- virus types in invasive cervical cancer worldwide : a meta- anal- ysis[ J]. Br J Cancer, 2003,88:63-73. 被引量:1

共引文献47

同被引文献172

引证文献14

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部